11β-Hydroxysteroid dehydrogenase type 1 inhibition in idiopathic intracranial hypertension: a double-blind randomized controlled trial

Treatment options for idiopathic intracranial hypertension are limited. The enzyme 11β-hydroxysteroid dehydrogenase type 1 has been implicated in regulating cerebrospinal fluid secretion, and its activity is associated with alterations in intracranial pressure in idiopathic intracranial hypertension...

Descripción completa

Detalles Bibliográficos
Autores principales: Markey, Keira, Mitchell, James, Botfield, Hannah, Ottridge, Ryan S, Matthews, Tim, Krishnan, Anita, Woolley, Rebecca, Westgate, Connar, Yiangou, Andreas, Alimajstorovic, Zerin, Shah, Pushkar, Rick, Caroline, Ives, Natalie, Taylor, Angela E, Gilligan, Lorna C, Jenkinson, Carl, Arlt, Wiebke, Scotton, William, Fairclough, Rebecca J, Singhal, Rishi, Stewart, Paul M, Tomlinson, Jeremy W, Lavery, Gareth G, Mollan, Susan P, Sinclair, Alexandra J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7425517/
https://www.ncbi.nlm.nih.gov/pubmed/32954315
http://dx.doi.org/10.1093/braincomms/fcz050

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7425517/
https://www.ncbi.nlm.nih.gov/pubmed/32954315
http://dx.doi.org/10.1093/braincomms/fcz050

Ejemplares similares